01889 SANAI HEALTH GP
- 0.027
- 0.0000.00%
SANAI HEALTH GP News
三愛健康集團：二零二三年年報
Sanai Health Group (01889.HK) issued a total of 612 million new shares due to the exchange of convertible stock notes
Sanai Health Group (01889.HK) issued an announcement to issue and distribute 349 million new shares on April 23, 2024 in exchange for convertible notes due 2026 with a principal amount of HK$34.2 million based on an adjusted conversion price of HK$0.098 per share.
Sanai Health Unit to Offload 59% Stake in Genetic Testing Provider
Sanai Health Industry Group (HKG:1889) unit Sanai International Investment will sell its 59% equity interest in Zentrogene Bioscience Laboratory to Merit Investment Holding for HK$22 million, accordin
Sanai Health Group (01889) plans to sell 59% of Zentrogene Bioscience Laboratory Limited's shares for HK$22 million
Sanai Health Group (01889) announced that on April 17, 2024, the company is a wholly-owned subsidiary of Sanai International Investment...
Sanai Health Group (01889) announced annual results. Profit attributable to shareholders was 18.633 million yuan, a year-on-year decrease of 36.23%
According to the Zhitong Finance App, Sanai Health Group (01889) announced its 2023 annual results, with revenue of about 122 million yuan (RMB, same below); a year-on-year decrease of about 30.59%; profit attributable to company owners was 18.633 million yuan, a year-on-year decrease of 36.23%; profit per share was 0.58 points. According to reports, the decline in earnings was mainly due to a decrease in sales of self-produced pharmaceutical products and sales of pharmaceutical products from other non-competitive pharmaceutical companies.
SANAI HEALTH GP: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
Sanai Health Industry Anticipates 40% Profit Decline in 2023
Sanai Health Industry Group (HKG:1889) expects to book a 40% year-over-year drop in net profit in 2023, according to a Monday filing with the Hong Kong bourse. The company attributed the anticipated d
Sanai Health Group (01889) Fa Ying Guang expects net profit attributable to owners to be reduced significantly by no more than 40% in 2023
Sanai Health Group (01889) announced that compared with the same period in 2022, the group is expected to achieve...
SANAI HEALTH GP: PROFIT WARNING
Sanai Health Group (01889.HK) plans to hold a board meeting on March 27 to consider and approve the annual results
Gelonghui, March 15, 丨 Sanai Health Group (01889.HK) announced that the company will hold a board meeting on March 27, 2024 (Wednesday) to consider and approve the audited financial results of the company and its subsidiaries for the financial year ended 31 December 2023.
Sanai Health Industry Group's Unit to Acquire Majority Stake in Technology Company
Sanai Health Industry Group Company's (HKG:1889) subsidiary Beijing Bafuluo Technology inked a deal to acquire a 51% equity stake in Beijing Hangyang Health Technology for 33.15 million yuan, the comp
Sanai Health Group (01889) plans to acquire 51% of Beijing Hangyang Health Technology's shares for 33.15 million yuan
Sanai Health Group (01889) announced that on March 1, 2024, the company's wholly-owned subsidiary Keibafro Technology Co., Ltd...
Court Orders Retrial of Sanai's Dispute With Beijing Cultural Technology
Sanai Health Industry Group (HKG:1889) provided an update on its legal dispute with Beijing Cultural Technology Finance Lease, saying the Higher People's Court of Beijing has dismissed the judgement p
Sanai Health Group (01889) received a civil ruling
Sanai Health Group (01889) issued an announcement. Regarding the lawsuit, as disclosed in the previous announcement, the company already in 2021...
SANAI HEALTH GP: Interim Report 2023
Sanai Health Group (01889) announced its interim results. Profit attributable to shareholders was 15.543 million yuan, an increase of 92.63% over the previous year
Sanai Health Group (01889) announced its interim results for the six months ended June 30, 2023, with a profit of 61...
SANAI HEALTH GP: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX-MONTH PERIOD ENDED 30 JUNE 2023
Sanai Health Group (01889.HK) held a board meeting on August 29 to consider and approve interim results
GLONGHUI August 17丨Sanai Health Group (01889.HK) announced that the company will hold a board meeting on August 29, 2023 (Tuesday) to consider and approve (among others) the Group's unaudited interim results for the six-month period ending June 30, 2023, as well as the payment of interim dividends (if any).
SANAI HEALTH GP: DATE OF BOARD MEETING
Sanai Health Group (01889): The court has yet to decide on the appeal
According to the Zhitong Finance App, Sanai Health Group (01889) issued an announcement. The company has filed an appeal against the civil judgment issued by the Beijing Fourth Intermediate People's Court dated December 22, 2020. The content relates to the lawsuit filed by Beijing Culture Technology Financial Leasing Co., Ltd. against the group. As of the date of this announcement, the appeal is being heard by the Beijing Higher People's Court, and the company has submitted a number of evidence and documents requested by the court. The court has yet to decide on the appeal.
Analysis
Price Target
No Data
